Roy A. Jensen, MD

Roy A. Jensen
Dr. Jensen was appointed the director of The University of Kansas Cancer Center (KU Cancer Center) in 2004. As a result of a broad-based university, community, and regional effort, The University of Kansas Cancer Center was designated as a cancer center by the National Cancer Institute (NCI) in July 2012. Dr. Jensen is currently Professor of Pathology and Laboratory Medicine, Professor of Anatomy and Cell Biology, Professor of Cancer Biology, and the William R. Jewell, M.D. Distinguished Kansas Masonic Professor at the University of Kansas Medical Center. Prior to his appointment at KU Cancer Center, Jensen was a member of the Vanderbilt-Ingram Cancer Center and a faculty member in Pathology, Cell Biology, and Cancer Biology for 13 years.

Dr. Jensen graduated from Vanderbilt University School of Medicine in 1984, and remained there to complete a residency in Anatomic Pathology and a Surgical Pathology fellowship with Dr. David Page. Following his clinical training he accepted a postdoctoral fellowship at the NCI in the laboratory of Dr. Stuart Aaronson. After he joined the faculty at Vanderbilt University, Dr. Jensen focused his research on understanding the function of BRCA1 and BRCA2 and their role in breast neoplasia, and in the characterization of premalignant breast disease at both the morphologic and molecular levels. He currently has over 150 scientific publications and has lectured widely on the clinical and molecular aspects of breast cancer pathology.

Dr. Jensen has served on numerous grant review panels, study sections, and site visit teams for the NIH, the Department of Defense-Breast Cancer Research Program, the Medical Research Council of Canada, the California Breast Cancer Research Program, and the Susan G. Komen Breast Cancer Foundation. Jensen serves on the Science Policy and Governmental Affairs Committees for the American Association for Cancer Research, and the Federation of American Societies for Experimental Biology. In addition, he is a member of the American Association of Cancer Researcher Publications Committee, and the Science Policy Working Group of the American Society for Investigative Pathology, and co-chairs the research committee for C-Change. In 2013, he chaired the program committee for AACI's annual meeting and was elected to the association's Board of Directors. Jensen also serves on Subcommittee A for the NCI; as Chair of the University of Oklahoma Stephenson Cancer Center External Advisory Board; and as a member of the Georgia Cancer Center, Augusta University External Advisory Board.